RecruitingPhase 2NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
Studying NON RARE IN EUROPE: Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- GlaxoSmithKline
- Principal Investigator
- GSK Clinical TrialsGlaxoSmithKline
- Intervention
- GSK4527226(drug)
- Enrollment
- 220 enrolled
- Eligibility
- 50-85 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- GSK Investigational Site, Maitland, Florida, United States
- GSK Investigational Site, Miami, Florida, United States
- GSK Investigational Site, Stuart, Florida, United States
- GSK Investigational Site, Toms River, New Jersey, United States
- GSK Investigational Site, Staten Island, New York, United States
- GSK Investigational Site, Matthews, North Carolina, United States
- GSK Investigational Site, Oklahoma City, Oklahoma, United States
- GSK Investigational Site, Houston, Texas, United States
- GSK Investigational Site, Fairfax, Virginia, United States
- GSK Investigational Site, Buenos Aires, Argentina
- GSK Investigational Site, Ciudad Autonoma de Buenos Aire, Argentina
- GSK Investigational Site, Ciudad Autonoma de Bueno, Argentina
- GSK Investigational Site, Macquarie Park, New South Wales, Australia
- GSK Investigational Site, Nedlands, Western Australia, Australia
- GSK Investigational Site, Ottawa, Ontario, Canada
- +15 more locations on ClinicalTrials.gov
Collaborators
Alector Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07105709 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Alzheimer disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07250113WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNorthwell Health
- RECRUITINGNCT07457138Lombard Cohort of Brain Health ServicesUniversity of Milano Bicocca
- RECRUITINGNANCT07286448Personalized Digital Training for COGnitive FITness in Mild Cognitive ImpairmentGiovanna Zamboni
- ACTIVE NOT RECRUITINGNANCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceUniversity of Milano Bicocca
- RECRUITINGNANCT07212504Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory ProblemsRotman Research Institute at Baycrest
- ENROLLING BY INVITATIONNANCT07168824An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionChi-Chang Huang
- ACTIVE NOT RECRUITINGNANCT07350226Electro-acupuncture for SCD With DepressionThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGNCT07402161The Signature of Alzheimer's Disease in Subjective Cognitive DeclineIRCCS Policlinico S. Donato